Docket
39172
Apotex Inc., et al. v. ADIR, et al.
(Federal) (Civil) (By Leave)
Judgments on applications for leave to appeal are rendered by the Court, but are not necessarily unanimous.
Date | Proceeding | Filed By (if applicable) |
---|---|---|
2021-09-08 | Close file on Leave | |
2021-09-08 | Correspondence (sent by the Court) to, all parties, Re: certificate of taxation | |
2021-09-02 | Certificate of taxation issued to, Judith Robinson | |
2021-09-02 | Decision on the bill of costs, in the amount of $1,021.60, DeRg | |
2021-09-02 | Submission of the bill of costs, DeRg | |
2021-07-30 | Correspondence (sent by the Court) to, parties, from Acting Registrar, Re: response to letter by counsel dated July 22, 2021 | |
2021-07-22 | Correspondence received from, Mr. Harry Radomski, Re: response to Acting Registrar letter not accepting reconsideration for filing | Apotex Inc. |
2021-07-14 | Correspondence (sent by the Court) to, parties, by the Acting Registrar, Re: reconsideration not accepted for filing | |
2021-07-14 | Reconsideration not accepted for filing | |
2021-03-23 | Response to the bill of costs, (Letter Form), Completed on: 2021-07-19, (Printed version due on 2021-03-30) | Apotex Inc. |
2021-03-23 | Bill of costs, (Book Form), Completed on: 2021-07-19, (Printed version due on 2021-03-30) | ADIR |
2021-03-03 | Letter acknowledging receipt of a complete motion for reconsideration | |
2020-12-02 | Correspondence received from, in response to applicant's reply | ADIR |
2020-12-01 | Reply to motion for reconsideration of the application for leave to appeal, Completed on: 2021-03-01 | Apotex Inc. |
2020-11-30 | Response to motion for reconsideration of the application for leave to appeal, Completed on: 2021-03-01 | ADIR |
2020-11-27 | Motion for reconsideration of the application for leave to appeal, (Book Form), Completed on: 2021-03-01 | Apotex Inc. |
2020-09-25 | Copy of formal judgment sent to Registrar of the Court of Appeal and all parties | |
2020-09-25 | Judgment on leave sent to the parties | |
2020-09-24 | Judgment of the Court on the application for leave to appeal, The application for leave to appeal from the judgment of the Federal Court of Appeal, Number A-128-18, 2020 FCA 60, dated March 11, 2020, is dismissed with costs. Dismissed, with costs |
|
2020-09-22 | Correspondence received from, (Letter Form), Responding to correspondence received 2020-09-21 | ADIR |
2020-09-21 | Correspondence received from, (Letter Form), Counsel for the Applicant writes to bring the Court's attention to the recent decision of the FCA in 2020 FCA 141 | Apotex Inc. |
2020-08-17 | All materials on application for leave submitted to the Judges, for consideration by the Court | |
2020-08-11 | Certificate (on limitations to public access), (Letter Form), 23B-Reply | Apotex Inc. |
2020-08-10 | Applicant's reply to respondent's argument, (Book Form), required: 23B to accompany reply (rec'd 2020/085/11), Completed on: 2020-08-11 | Apotex Inc. |
2020-07-30 | Certificate (on limitations to public access), (Letter Form), 23B | ADIR |
2020-07-30 | Certificate (on limitations to public access), (Letter Form), 23A | ADIR |
2020-07-30 | Notice of name, (Letter Form) | ADIR |
2020-07-30 | Respondent's response on the application for leave to appeal, (Book Form), Completed on: 2020-07-30 | ADIR |
2020-06-09 | Correspondence received from, (Letter Form), respondents will file a response to the application for leave in this matter, but additional time is required in light of COVID-19 | ADIR |
2020-05-20 | Letter acknowledging receipt of a complete application for leave to appeal, FILE OPENED 2020-05-20 | |
2020-05-20 | Certificate (on limitations to public access), (Letter Form), 23B required: amended 23B (rec'd 2020/05/20) |
Apotex Inc. |
2020-05-20 | Certificate (on limitations to public access), (Letter Form), 23A | Apotex Inc. |
2020-05-20 | Notice of name, (Letter Form) | Apotex Inc. |
2020-05-11 | Application for leave to appeal, (Book Form), required: -amended 23B (rec'd 2020/05/20) -amended application (rec'd 2020/05/21), Completed on: 2020-05-20 |
Apotex Inc. |
- Date modified: